MENU
 Pharmaceutical Manufacturers Association of Japan
  • Contact Us
  • Access
  • English
  • About us

    About Pharmaceutical Manufacturers Association Top

    • Top Message
    • Outline of the Pharmaceutical Manufacturers Association of Japan
    • Policies and Activities
    • Voluntary Standards
    • Industry Vision and Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • Newsletter
  • News Room

    Newsroom Top

    • News Release
    • Pharmaceutical Association of Japan Newsletter
    • Updates
    • Publications
    • Events
    • Video Content and Advertisements
  • Pharmaceutical Industry Policy Institute
Close
 Pharmaceutical Manufacturers Association of Japan

Return to Site Top

  • Patients and the general public (About Pharmaceuticals)
    For Patients and the Public (About Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • About us
    About Pharmaceutical Manufacturers Association Top
    • Top Message
    • Outline of the Pharmaceutical Manufacturers Association of Japan
    • Policies and Activities
    • Voluntary Standards
    • Industry Vision and Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • Pharmaceutical Association Code of Practice
    • Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions
    • Transparency Guidelines for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Philosophy and Action Guidelines on Biodiversity
    • Guidelines for Appropriate Competition in the Meetings of the Japan Pharmaceutical Manufacturers Association (JPMA)
    • Guidelines for the Promotion of Pharmaceutical Industry
  • News Room
    Newsroom Top
    • News Release
    • Pharmaceutical Association of Japan Newsletter
    • Updates
    • Publications
    • Events
    • Video Content and Advertisements
  • Pharmaceutical Industry Policy Institute Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Industry Vision, Policy Recommendations
    Industry Vision and Policy Recommendations Top
    • Toward the realization of the Pharmaceutical Manufacturers Association of Japan Industry Vision 2035
    • Chairman's Press Conference, Speeches and Comments
    • Back Number: Vision, Proposals
  • Contact Us
  • Access
  • English
  • Top
  • Information from the Committee
  • Industry Policy Committee
  • Event Report

Event Report

  • Nikkan Yakugyo [Serials <1>] Pharmaceuticals also a Growth Market, Indicators and Estimates Chairman of the Industrial Policy Committee of the Pharmaceutical Manufacturers Association of Japan, Mr. Iwashita

    Published in Nikkan Yakugyo on August 29, 2025 [license number 20250829_01].
    Jiho Co., Ltd. has granted permission for use of the article.

  • To Deliver Necessary Drugs to Patients - Pharmaceutical Manufacturers Association Urges Government to Strengthen Support for Unapproved Drugs

    Published in Nikkan Yakugyo July 15, 2025

  • JAPIA Members Participate in DIA 2025 Global Annual Meeting and Communicate to the World about Efforts to Address Drug Lag and Loss Issues

    Date: June 18, 2025

  • The Pharmaceutical Association of Japan Media Forum
    Diverse Values of Pharmaceuticals "Diverse Values of New Modalities: Case Study of Spinal Muscular Atrophy (SMA)

    Date: March 7, 2025

  • Rare Disease Day 2025 Symposium

    Date: February 9, 2025
    Co-sponsored by: RDD Japan Secretariat

  • Economic Security Seminar "The Latest Trends of Cyber Threats and the Pharmaceutical Industry

    Date: November 25, 2024

  • Rare Disease Day 2024 Symposium

    Date: February 4, 2024
    Co-sponsored by: RDD Japan Secretariat

  • Economic Security Seminar "Economic Security and Cyber Security

    Date: September 26, 2023

  • Economic Security Seminar "Economic Security and Pharmaceutical Industry

    Date: June 26, 2023

Share this page

  • Tweet
  • Share this page

TOP

Site Search

  • Top
  • Information from the Committee
  • Industry Policy Committee
  • Event Report
  • Pharmaceutical Association of Japan PR and Communication Activities
  • Pharmaceutical Research Institute
  • Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • What is the Pharmaceutical Manufacturers Association of Japan (PMAJ)?
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • News Room
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • English Page will open in a new window.
  •  x
  •  facebook
  •  youtube
  • Site Map
  • Contact Us
  • Website Terms of Use
  • Privacy Policy
  • Social Media Policy
  • Linking to Our Site
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).All rights reserved.